In conclusion, the current comprehensive study provides multiple lines of evidence for supporting DALRD3, LDHA, HEBP2, TEX264, and FGFR3 as insomnia-associated genes whose abnormal expression level may convey risk to insomnia. This evidence concerns the gene LDHA and insomnia measurement.